RE: Has another drug that failed a P3 trial been approved before?9 Mar 2022 06:59
Tommy
Good find, as they say put that in your pipe and smoke it.
Andy
I’m as peed off as anyone on here, as I’m way down.
However, the speculation is continued by you when you keep throwing these timelines of 5-10 years about. Read the RNS, listen to the company and what they are saying.
‘The SPRINTER trial pointed to an encouraging trend in prevention of progression to severe disease and death (36% reduction in the pre-defined per protocol population), which the Company and its clinical advisors strongly believe merits further investigation in a platform trial which the Company is actively investigating.’
Where does it say this will take 5-10 years?
Deep dive could unearth some gems, so can Activ 2.
Are Polygon buying because they are stupid?
I/v results are excellent.
We still have to believe, although I am with you in that I’m extremely frustrated at RM and his lack of presence, even just to show his face and add leadership and support and possible reassurance that we are still invested in the right company.
GLA